10. February 2014
In 2013, the global economy was once again characterised by uncertainty and reticence. In this difficult environment, Geistlich Pharma AG again asserted itself very well as a Swiss SME. The company posted solid growth and strengthened or even expanded its position in virtually all its markets. Once again, the balanced geographical mix, an attractive product pipeline and the operational strength of the company were contributing factors.